ArticleBMC medicine2022

Palbociclib-based high-throughput combination drug screening identifies synergistic therapeutic options in HPV-negative head and neck squamous cell carcinoma.

Ziyue Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.